Medical News Summary: Health Canada warns consumers about various COX-2 inhibitor NSAIDs

About: Health Canada warns consumers about various COX-2 inhibitor NSAIDs
Date: 23 December 2004
Source: Medical News Today
Medical News Summary (summary of medical news story as reported by Medical News Today): Health Canada is advising consumers about the safety concerns associated with selective COX-2 inhibitor NSAIDs (non-steroidal anti-inflammatories) such as Vioxx, Celebrex, BExtra and Mobicox which are used to treat rheumatoid arthritis, osteoarthritis and menstrual pain (primary dysmenorrhea). The safety concerns raised revolve around the increased risk of heart attack or stroke in some people. The risk appears directly related to dosage and length of treatment. Vioxx has already been withdrawn due to increased risk of heat attack and stroke after 18 months of use.
URL: http://www.medicalnewstoday.com/medicalnews.php?newsid=18255
Related Disease Topics: Arthritis, Rheumatoid arthritis, Osteoarthritis, Menstrual pain, Primary dysmenorrheal, Heart attack, Stroke

---

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

• Medication
• medication and arthritis
• medication and rheumatoid arthritis
• medication and osteoarthritis
• medication and menstrual pain
• Medication and primary dysmenorrheal
• medication and heart attack
• medication and stroke
• risk and arthritis
• risk and rheumatoid arthritis
• risk and osteoarthritis
• risk and menstrual pain
• Risk and primary dysmenorrheal
• risk and heart attack
• risk and stroke
• cause of heart attack
• cause of stroke
• death and heart attack
• death and stroke

Medical Tools & Articles:

Next articles:

• Risk Factor Center
• Medical Statistics Center
• Medical Treatment Center
• Prevention Center
• Medical Tests Center

Medical Articles:

• Disease & Treatments Search
• Online Diagnosis
• Misdiagnosis Center
• Full list of interesting articles